Who Owns Celebrex?
Celebrex is owned by Pfizer, a publicly traded American multinational pharmaceutical company. Celebrex is Pfizer's COX-2 inhibitor pain relief medication. Pfizer is headquartered in New York, USA and trades on NYSE (PFE).
Parent Company
Pfizer
Founded
1998
Status
Publicly Traded
Headquarters
New York, New York, USA
Who Owns Celebrex?
- Parent Company: Pfizer
- Ownership Type: Wholly owned
- Company Type: Publicly Traded
- Stock Ticker: NYSE: PFE
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Celebrex | Pfizer | Wholly owned |
History of Celebrex
- Founded: 1998
- Founders: Pfizer (internal development)
Celebrex was developed by Pfizer through extensive research into cyclooxygenase-2 inhibition for treating arthritis pain and inflammation. The drug was approved by the FDA in 1998 as a treatment for osteoarthritis and rheumatoid arthritis. Celebrex represented an important advancement in pain management, offering patients a selective COX-2 inhibitor with potentially fewer gastrointestinal side effects. This breakthrough development demonstrated exceptional scientific insight into the growing demand for safer, more effective pain management options while establishing a distinctive therapeutic approach that would define COX-2 inhibitor treatment for generations.
The development of Celebrex involved years of research into COX-2 selectivity and anti-inflammatory mechanisms. Pfizer conducted extensive clinical trials demonstrating the drug's efficacy in treating arthritis pain and inflammation. Celebrex quickly became one of the most prescribed pain relief medications globally. This period of research and development demonstrated Pfizer's exceptional ability to invest in pharmaceutical innovation while maintaining rigorous scientific standards and clinical trial protocols that would define the company's approach to drug development.
Following its initial approval, Celebrex became available in multiple strengths and formulations. The drug's effectiveness in treating arthritis pain made it a standard treatment option for patients with osteoarthritis and rheumatoid arthritis. Celebrex became one of Pfizer's most successful pain relief products. This successful market introduction demonstrated Pfizer's ability to translate scientific innovation into commercial success while establishing a competitive advantage in the pain management market.
In recent decades, Celebrex has continued to maintain its position as a leading pain relief and anti-inflammatory medication. The drug has been approved in numerous countries worldwide and has become a standard therapy for arthritis pain. Celebrex remains one of the most widely prescribed COX-2 inhibitors in the market. This sustained success demonstrates Celebrex's ability to adapt to changing medical standards and regulatory requirements while maintaining its core therapeutic value and clinical effectiveness in treating arthritis pain and inflammation.
About Pfizer
What does Pfizer own?
Pfizer owns a portfolio of prescription medicines and vaccines spanning oncology, cardiovascular, immunology, vaccines, and rare diseases. Key products include Eliquis (blood thinner), Prevnar (pneumococcal vaccine), Ibrance (breast cancer), Vyndaqel (rare heart disease), Paxlovid (COVID-19 antiviral), and Comirnaty (COVID-19 vaccine, with BioNTech). The 2023 acquisition of Seagen added oncology antibody-drug conjugates including Padcev, Adcetris, and Tukysa.
Is Pfizer publicly traded?
Yes, Pfizer Inc. is listed on the New York Stock Exchange under ticker PFE. The company has been publicly traded since 1944. Pfizer has no single controlling shareholder, with major institutional holders including Vanguard Group, BlackRock, and State Street. Pfizer is a component of the Dow Jones Industrial Average and the S&P 500.
Who founded Pfizer?
Pfizer was founded in 1849 in Brooklyn, New York by Charles Pfizer and his cousin Charles Erhart. Charles Pfizer was a German-born chemist who emigrated to the United States. The company's first product was santonin, an antiparasitic agent. Pfizer's breakthrough into modern pharmaceuticals came during World War II when the company developed large-scale penicillin production.
Where is Pfizer headquartered?
Pfizer is headquartered in New York City, New York, USA. The company maintains its principal executive offices in Midtown Manhattan. Pfizer operates manufacturing facilities in the United States, Belgium, Ireland, the United Kingdom, Germany, Japan, China, India, and Brazil, and sells products in more than 125 countries worldwide.
How many products does Pfizer sell?
Pfizer sells dozens of prescription medicines and vaccines across multiple therapeutic areas. The company's portfolio includes products in oncology, vaccines, cardiovascular, immunology, rare diseases, and hospital products. More than a dozen of Pfizer's products each generate over $1 billion in annual revenue. The company's research pipeline includes hundreds of compounds in various stages of clinical development.
Who owns Pfizer?
Pfizer Inc. is publicly traded on the NYSE with a broad institutional and retail shareholder base. No single shareholder holds a controlling stake. Major institutional shareholders include Vanguard Group, BlackRock, and State Street. Albert Bourla serves as Chairman and CEO. Pfizer has no founding family or private equity controlling shareholder.
- Founded: 1849
- Headquarters: New York, New York, USA
- Company Type: Publicly Traded
- Stock: NYSE: PFE
Where Is Celebrex Made / Based?
- Headquarters: New York, New York, USA
- Manufacturing / Operations: United States, Belgium, Ireland, United Kingdom
Brands Owned by Pfizer
- Diflucan - Prescription antifungal medication for treating fungal infections including cand...
- Eliquis - Prescription anticoagulant medication for preventing blood clots and stroke in p...
- Leucovorin - Generic prescription folinic acid (5-formyltetrahydrofolate) used for methotrexa...
- Norvasc - Prescription calcium channel blocker medication for treating high blood pressure...
Celebrex Ownership: Pros & Cons
Advantages
- +Selective COX-2 inhibitor for arthritis pain relief
- +Proven efficacy in treating osteoarthritis and rheumatoid arthritis
- +Available in multiple strengths for different patient needs
- +Backed by extensive clinical research and safety data
- +Supported by Pfizer's research capabilities and pharmaceutical expertise
- +Available globally with established distribution networks
- +Improved pain control and quality of life for arthritis patients
Considerations
- -Potential cardiovascular side effects with long-term use
- -Potential gastrointestinal side effects despite COX-2 selectivity
- -Not suitable for patients with certain heart conditions
- -Requires monitoring by healthcare professionals
- -Competition from other pain relief medications
- -Potential for drug interactions with other medications
- -May not be effective for all types of arthritis pain
Frequently Asked Questions About Celebrex
Where to Buy
Disclosure: We may earn commission from purchases
Celebrex on AmazonCompetitors to Celebrex
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Novartis | Switzerland | 2015 | Mass Market | Global | All Genders | |
| Kenvue | USA | 1974 | Mass Market | North America | All Genders | |
| Haleon | United Kingdom | 1976 | Mass Market | Global | All Genders | |
| Novartis | Switzerland | 2009 | Mass Market | Global | All Genders | |
| Takeda | Japan | 2018 | Mass Market | Asia Pacific | All Genders | |
| Merck | USA | 2008 | Mass Market | North America | All Genders |
Learn More About Competitors
Cosentyx
Owned by Novartis
Prescription biologic medication for treating autoimmune diseases including psoriasis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and other inflammatory conditions.
Motrin
Owned by Kenvue
American brand of ibuprofen pain relief medication owned by Kenvue, the consumer health spinoff from Johnson & Johnson, which is being acquired by Kimberly-Clark in a $40 billion deal announced in November 2025.
Voltaren
Owned by Haleon plc
Over-the-counter anti-inflammatory pain relief brand containing diclofenac, owned by Haleon plc (LSE/NYSE: HLN) since its July 2022 spinoff from the GSK and Pfizer consumer health joint venture, with Voltaren growing mid-single digit in full-year 2025 supported by new format patches and Voltadexibu launches.
Afinitor
Owned by Novartis
Prescription oncology medication for treating various cancers including renal cell carcinoma and breast cancer, manufactured and marketed by Novartis.
Alofisel
Owned by Takeda Pharmaceutical Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Bridion
Owned by Merck & Co.
Prescription medication for reversing neuromuscular blockade during anesthesia, manufactured and marketed by Merck & Co.
Competitive Analysis
Market Positioning: Celebrex competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Pfizer Stock Information
Jobs at Pfizer
Latest News About Celebrex
Related Articles About Celebrex
View more articles
Pharmaceutical Brand Ownership: A Complete Guide
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
Brand Spin-offs: When Companies Sell Off Their Own Brands
From Kenvue to Kellanova, major corporations are spinning off iconic brands into independent companies. Learn why, how it works, and what it means for consumers.
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.
Acuvue
American brand of contact lenses and vision care products specializing in daily disposable and extended wear contact lenses, manufactured and marketed by Johnson & Johnson.
Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.